Table 6. Patient Characteristics by... | American Society of Hematology

Table 6.

Patient Characteristics by Histologic Type

Consensus Diagnosis	% Male	Median Age	% Stage 1 or 2	% Marrow Positive	% PI 0/1	% PI 4/5	% 5-yr OAS	% 5-yr FFS
Follicular, all grades	42	59	33	42	39	6	72	40
Mantle cell	74	63	19	63	19	19	27	11
Marginal zone B-cell, MALT	45	61	66	14	38	5	74	60
Marginal zone B-cell, nodal	41	58	18	41	36	9	57	29
Small lymphocytic (CLL)	53	65	6	73	17	10	51	25
Lymphoplasmacytoid	53	63	20	73	20	13	59	25
Diffuse large B-cell	55	64	51	17	31	16	46	41
Primary mediastinal large B-cell	34	37	66	3	44	9	50	48
Burkitt's	89	31	56	33	44	22	44	44
High-grade B-cell, Burkitt-like	59	55	50	21	25	18	47	43
Precursor T-lymphoblastic	74	25	13	43	35	22	26	24
Peripheral T-cell, all types	56	61	18	37	14	27	25	18
Anaplastic large T/null-cell	69	33	50	12	50	19	77	58

Consensus Diagnosis	% Male	Median Age	% Stage 1 or 2	% Marrow Positive	% PI 0/1	% PI 4/5	% 5-yr OAS	% 5-yr FFS
Follicular, all grades	42	59	33	42	39	6	72	40
Mantle cell	74	63	19	63	19	19	27	11
Marginal zone B-cell, MALT	45	61	66	14	38	5	74	60
Marginal zone B-cell, nodal	41	58	18	41	36	9	57	29
Small lymphocytic (CLL)	53	65	6	73	17	10	51	25
Lymphoplasmacytoid	53	63	20	73	20	13	59	25
Diffuse large B-cell	55	64	51	17	31	16	46	41
Primary mediastinal large B-cell	34	37	66	3	44	9	50	48
Burkitt's	89	31	56	33	44	22	44	44
High-grade B-cell, Burkitt-like	59	55	50	21	25	18	47	43
Precursor T-lymphoblastic	74	25	13	43	35	22	26	24
Peripheral T-cell, all types	56	61	18	37	14	27	25	18
Anaplastic large T/null-cell	69	33	50	12	50	19	77	58

Abbreviations: PI, International Prognostic Index; OAS, overall survival; FFS, failure-free survival; CLL, chronic lymphocytic leukemia.